Purchase Order 75N95023P00523
Award Date
8/8/23
Potential Completion Date
9/19/23
Potential Value
$56K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Promega Corporation
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Promega Corporation, a global life sciences company, to provide P450-Glo screening systems including CYP26A1, CYP26B1, and CYP3A4 assay kits. The $123,592.50 contract supports the Tox21 collaboration between NCATS, the National Toxicology Program, EPA, and FDA, which aims to screen thousands of compounds in vitro to develop better toxicity...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation for $132,961.50. The order is for Promega's cytochrome P450 screening assay systems to support the Tox21 drug screening program. The assay kits measure the activity of various CYP enzymes, which are critical for evaluating drug metabolism and toxicity. This award was sole-sourced to Promega as the sole...
This is a $127,908.40 firm fixed-price purchase order awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The award is for Promega's proprietary reagent kits and assay products, which are sole source procured due to their specialized capabilities required to support NCATS' ongoing laboratory research and high-throughput screening programs. This award was not...
This is a $83,800 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation. The award is to procure custom Promega assays and reagents, including the MTase-Glo Methyltransferase Assay, to support NCATS's Antiviral Program for Pandemics. The award is non-competitive as Promega's reagents are specifically engineered and optimized for NCATS's high-throughput screening and...
The National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, awarded a Firm Fixed Price Purchase Order contract to Promega Corporation, a for-profit manufacturer of biological research and diagnostic products. The $66,970.35 contract is for the delivery of Promega's proprietary laboratory equipment, reagents, and consumables to support the agency's biomedical research and testing programs. This award is under a $10 million...
This firm-fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS) within the Department of Health and Human Services' National Institutes of Health. The $121,492.50 contract is for the procurement of detection assay systems with an August 2021 completion date. Promega has previously been awarded prime and subcontracts by various agencies including the NIH, CDC, DoD, and FBI to provide DNA...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed-price purchase order to Promega Corporation for P450-Glo Assay Systems. The $143,461.50 contract is for the supply of 65 units each of CYP3A4, CYP2D6, and CYP1A2 assay kits to support the Toxicology in the 21st Century (Tox21) program's efforts to screen compounds for effects on cytochrome P450 enzyme activities. Promega is a global life sciences...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Promega Corporation for a methyltransferase assay kit, consisting of 2,000 assays. The $45,504.00 contract is to support NCATS' mission of catalyzing innovative methods and technologies for developing diagnostics and therapeutics. The assay kits will be used in NCATS' methyltransferase project to identify...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services. The $86,800.00 contract is for Promega Corporation, a global life sciences company, to provide reagent kits and assays. The award is not set aside for any small business designations. Promega holds several significant federal contract vehicles, including Blanket Purchase Agreements with the Defense Health...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $38,508 firm fixed price purchase order to Promega Corporation of Madison, Wisconsin. The order is for luminescence detection reagents including Promega product numbers G8092, G8093, G9713, and N1150 to support ongoing high-throughput screening of internal libraries for viruses such as Rift Valley Fever Virus and SARS-CoV-2. The reagents will be used to...